The Management of Psychological Issues in Oncology

  Abstract: Psychological issues in the cancer setting are highly prevalent and well documented, and can lead to adverse outcomes. Several series of guidelines have been […]

CD19-Targeted CAR T Cells as Novel Cancer Immunotherapy for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

Clinical Advances in Hematology & Oncology October 2016, Volume 14, Issue 10 Marco L. Davila, MD, PhD, and Renier J. Brentjens, MD, PhD Dr Davila is […]

The Role of High-Dose Melphalan and Autologous Stem Cell Transplant in the Rapidly Evolving Era of Modern Multiple Myeloma Therapy

Clinical Advances in Hematology & Oncology Volume 14, Issue 9, September 2016 Peter M. Voorhees, MD, and Saad Z. Usmani, MD The authors are affiliated with […]

Bruton’s Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia and Lymphoma

Clinical Advances in Hematology & Oncology Volume 14, Issue 7, July 2016 Gaurav Varma, MSPH, Tyler P. Johnson, MD, and Ranjana H. Advani, MD Mr Varma […]

Resistance Exercise Training in Patients With Genitourinary Cancers to Mitigate Treatment-Related Skeletal Muscle Loss

Clinical Advances in Hematology & Oncology Volume 14, Issue 6, June 2016 Oliver K. Glass, PhD, Sundhar Ramalingam, MD, and Michael R. Harrison, MD Dr Glass […]

Challenges of Conducting Clinical Trials of Natural Products to Combat Cancer

Clinical Advances in Hematology & Oncology Volume 14, Issue 6, June 2016 Channing J. Paller, MD, Samuel R. Denmeade, MD, and Michael A. Carducci, MD The […]

Approach to the Surgical Management of Resectable Gastric Cancer

Clinical Advances in Hematology & Oncology April 2016, Volume 14, Issue 4 Humair S. Quadri, MD, Young K. Hong, MD, and Waddah B. Al-Refaie, MD The […]

Role of the Androgen Receptor in Triple-Negative Breast Cancer

Clinical Advances in Hematology & Oncology March 2016, Volume 14, Issue 3 Murtuza Rampurwala, MD, MPH, Kari B. Wisinski, MD, and Ruth O’Regan, MD The authors […]

Approach to the Surgical Management of Resectable Gastric Cancer

Clinical Advances in Hematology & Oncology March 2016, Volume 14, Issue 3 Humair S. Quadri, MD, Young K. Hong, MD, and Waddah B. Al-Refaie, MD The […]

Approach to the Medical Management of Surgically Resectable Gastric Cancer

Clinical Advances in Hematology & Oncology February 2016, Volume 14, Issue 2 Anteneh Tesfaye, MD, John L. Marshall, MD, and Brandon G. Smaglo, MD The authors […]

A Paradigm Shift From One-Size-Fits-All to Tailor-Made Therapy for Metastatic Colorectal Cancer

Clinical Advances in Hematology & Oncology February 2016, Volume 14, Issue 2 Benjamin A. Weinberg, MD, John L. Marshall, MD, Marion Hartley, PhD, and Mohamed E. […]

Upper Tract Urothelial Carcinoma: Special Considerations

Clinical Advances in Hematology & Oncology February 2016, Volume 14, Issue 2 Ryan Hutchinson, MD, Ahmed Haddad, MD, PhD, Arthur Sagalowsky, MD, and Vitaly Margulis, MD […]

B-Cell Receptor Signaling in Chronic Lymphocytic Leukemia and Other B-Cell Malignancies

Clinical Advances in Hematology & Oncology January 2016, Volume 14, Issue 1   Stefan Koehrer, MD, and Jan A. Burger, MD The authors are affiliated with […]

Emerging Therapies in Relapsed and Refractory Peripheral T-Cell Lymphoma

Clinical Advances in Hematology & Oncology December 2015, Volume 13, Issue 12 Spencer H. Bachow, MD, and Owen A. O’Connor, MD, PhD The authors are affiliated […]

Advances in Immunotherapy for Non–Small Cell Lung Cancer

Clinical Advances in Hematology & Oncology December 2015, Volume 13, Issue 12 Karen L. Reckamp, MD Dr Reckamp is an associate professor in the Department of […]

Programmed Death 1 Immune Checkpoint Inhibitors

Clinical Advances in Hematology & Oncology December 2015, Volume 13, Issue 12 Meghna S. Trivedi, MD, Brianna Hoffner, BA, RN, MSN, Jennifer L. Winkelmann, BSN, RN, […]

Moving Toward Targeted Therapies in Acute Myeloid Leukemia

Clinical Advances in Hematology & Oncology November 2015, Volume 13, Issue 11 Weiqiang Gao, MD, PhD, and Elihu Estey, MD Dr Gao is a clinical fellow […]

Neoadjuvant Breast Cancer Therapy and Drug Development

Clinical Advances in Hematology & Oncology November 2015, Volume 13, Issue 11 Patricia Cortazar, MD, and Paul G. Kluetz, MD The authors are affiliated with the […]

Immune Therapy in Multiple Myeloma

Clinical Advances in Hematology & Oncology November 2015, Volume 13, Issue 11 Katarina Luptakova, MD, and David Avigan, MD Dr Luptakova is a hematologist-oncologist affiliated with […]

PD-1/PD-L1 Immune Checkpoint Blockade in Non–Small Cell Lung Cancer

Stephen J. Bagley, MD, Joshua M. Bauml, MD, and Corey J. Langer, MD The authors are affiliated with the division of hematology/oncology at the Abramson Cancer […]